Ultrasound-guided Percutaneous Neuromodulation in Anterior Cruciate Reconstruction

The objective of the study is to demonstrate the efficacy of the ultrasound-guided percutaneous neuromodulation technique in the femoral nerve in patients who underwent surgery for the anterior cruciate ligament.

Inclusion Criteria:Subjects aged between 18 and 55 years who have undergone surgery for an anterior cruciate ligament (ACL) in a period of time between 2 and 6 weeks of evolution with or without meniscal injury (meniscal regularization / meniscal suture / meniscectomy, etc.).have pain or loss of sensitivity in the operated knee and that they have signed the informed consent.Exclusion Criteria:Subjects with chronic joint disease; prosthesis or osteosynthesis in the intervention area, as well as heart disease, neoplasia and coagulopathy.Subjects consuming analgesics.Subjects with belonephobia or insurmountable fear of needlesHistory of lumbar pathology (lumbar hernia/protrusion) due to possible involvement of the lumbar plexus.Subjects with a history of neurological or orthopedic disordersSubjects with bilateral symptoms.Subjects with epilepsy, pacemaker or pregnant.